Textsize

  • Textsize Middle
  • Textsize Large

EN

検索

JP

Menu

閉じる

Division of Hematology and Oncology

Subject Division of Hematology and Oncology
Staff
Professor Junya Kuroda
Associate Professor Shigeo Horiike
Assistant Professor Tsutomu Kobayashi, Yuji Shimura, Taku Tsukamoto
Research Conact  
  • Analysis of cytogenetic abnormalities and gene mutations which associated with hematological malignancies
  • Exploratory basic research for the development of a new molecular targeted therapy.
  • Clinical study for the improvement of hematopoietic cell transplantation.
  • Clinical study to establish therapeutic strategies for incurable hematological malignancies.
  • Case reports for rare hematological diseases or unique therapies at special situations. 
Achievements
Kawaji Y, Nagata H, Muramatsu A, Kuriyama K, Ohshiro M, Hirakawa Y, Iwai T, Kobayashi T, Uchiyama H, Urata Y, Kuroda J. Diffuse large B-cell lymphoma with chromosomal translocation t(14;19)(q32;q13) occurring in IgG4-related disease. Ann Hematol, in print.
 
Matsumoto Y, Kobayashi T, Shimura Y, Kawata E, Nagoshi H, Ohshiro M, Sugitani M, Shimura K, Iwai T, Fuchida S, Yoshida M, Kiyota M, Mizutani S, Chinen Y, Takimoto-Shimomura T, Nakao M, Kaneko H, Uchiyama H, Uoshima N, Nishigaki H, Kobayashi Y, Horiike S, Shimazaki C, Taniwaki M, Kuroda J; Kyoto Clinical Hematology Study Group. Combined chemotherapy of rituximab, bendamustine and dexamethasone for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma: A multicenter phase II study. Int J Hematol, in print.
 
Yamaguchi J, Fujino T, Isa R, Nishiyama D, Kuwahara-Ota S, Tsukamoto T, Chinen Y, Shimura Y, Kobayashi T, Horiike S, Kohno K, Nakamura S, Kuroda J. Epstein-Barr virus-associated lymphoproliferative disease during imatinib mesylate treatment for chronic myeloid leukemia. Haematologica, in print.(名古屋大学臓器病態診断学との共同研究)
 
Mizuno Y, Chinen Y, Tsukamoto T, Takimoto-Shimomura T, Matsumura-Kimoto, Fujibayashi Y, Fujino T, Nishiyama D, Shimura Y, Kobayashi T, Horiike S, Taniwaki M, Kuroda J. A novel method of amplified fluorescent in situ hybridization for detection of chromosomal microdeletions in B cell lymphoma. Int J Hematol, in print.
 
Sasaki N, Shimura K, Yoshida M, Uoshima N, Kiyota M, Hatsuse M, Uchiyama H, Chinen Y, Kobayashi T, Nakao M, Takahashi R, Nakano-Akamatsu S, Kaneko H, Kobayashi Y, Shimazaki C, Taniwaki M, Kuroda J; The Kyoto Clinical Hematology Study Group (KOTOSG) investigators. Immunosuppressive therapy with rabbit antithymocyte globulin therapy for acquired aplastic anemia: a multi-institutional retrospective study in Japanese adult patients. Int J Hematol, 109: 278-285, 2019. (京都府立医科大学生物統計学教室、血液内科と関連施設の共同研究)
 
Takamatsu H, Yamashita T, Kurahashi S, Saitoh T, Kondo T, Maeda T, Nakazawa H, Murata M, Narita T, Kuroda J, Hashimoto H, Kawamura K, Miyamoto T, Honda S, Ichinohe T, Atsuta Y, Sunami K. Clinical implications of t(11;14) in patients with multiple myeloma undergoing autologous stem cell transplantation. Biol Bone Marrow Transplant, in print. (多施設共同研究)
 
Kasamatsu T, Ozaki S, Saitoh T, Konishi J, Sunami K, Itagaki M, Asaoku H, Cho T, Handa H, Hagiwara S, Wakayama T, Negoro A, Takezako N, Harada N, Kuroda Y, Nakaseko C, Miyake T, Inoue N, Hata H, Shimazaki C, Ohno T, Kuroda J, Murayama T, Takahashi N, Abe M, Ishida T, Nagura E, Shimizu K. Unsuppressed serum albumin levels may jeopardize the clinical relevance of the international staging system to patients with light chain myeloma. Hematol Oncol, 36: 792-800, 2018. (多施設共同研究)
 
Takimoto-Shimomura T, Tsukamoto T, Maegawa S, Fujibayashi Y, Matsumura-Kimoto Y, Mizuno Y, Chinen Y, Shimura Y, Mizutani S, Horiike S, Taniwaki M, Kobayashi T, Kuroda J. Dual targeting of bromodomain-containing 4 by AZD5153 and BCL2 by AZD4320 against B-cell lymphomas concomitantly overexpressing c-MYC and BCL2. Invest New Drugs, in print.
 
Inoue Y, Nakamura T, Nakanishi H, Oishi M, Hongo F, Okihara K, Mizutani S, Kuroda J, Ukimura O. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients. Int J Urol, 25: 678-683, 2018.(京都府立医科大学泌尿器科との共同研究)
 
Takimoto-Shimomura T, Nagoshi H, Maegawa S, Fujibayashi Y, Tsukamoto T, Mastumura-Kimoto Y, Mizuno Y, Chinen Y, Mizutani S, Shimura Y, Horiike S, Taniwaki M, Kobayashi T, Kuroda J. Establishment and Characteristics of a Novel Mantle Cell Lymphoma-derived Cell Line and a Bendamustine-resistant Subline. Cancer Genomics Proteomics, 15:213-223, 2018
Contact
TEL: 81-75-251-5740
FAX: 81-75-251-5743
e-mail: t-koba@koto.kpu-m.ac.jp
HP http://www.f.kpu-m.ac.jp/k/hematol/

602-8566 Kyoto-shi, Kamigyo-ku Kajii-cho,
Kawaramachi-Hirokoji, JAPAN

Contact
TEL:075-251-5111
FAX:075-251-7093